About 2,340,000 results
Open links in new tab
  1. R&D Blueprint - World Health Organization (WHO)

    Jan 1, 2019 · The R&D Blueprint is a global strategy and preparedness plan that allows the rapid activation of research and development activities during epidemics. Its aim is to fast-track the …

  2. Ebola | Pandemic PACT Tracker

    A WHO-led ring vaccination trial using IAVI’s rVSV-based SUDV vaccine candidate has begun, and the first participants have been vaccinated as of 3 February 2025.

  3. Ebola vaccine: transforming global health responses

    Apr 17, 2025 · While this was a breakthrough for Ebola, this vaccine is only effective against the Zaire strain. There is still more research and innovation needed to protect vulnerable …

  4. WHO R&D roadmaps

    Each roadmap will serve as a collaborative framework to underpin strategic goals and research priority areas so as to accelerate the development of diagnostics, therapeutics and vaccines to …

  5. Ebola-hit Uganda begins vaccination trial: WHO - ABS-CBN News

    Feb 4, 2025 · A system for candidate vaccines was put in place during a previous outbreak of the Ebola Sudan virus in Uganda in 2022, paving the way for a trial during the next outbreak, the …

  6. Infectious Disease R&D Tracker | Impact

    The Infectious Disease R&D pipeline tracker is an authoritative database of approved health products and technologies, as well as active candidates in the development pipeline, for …

  7. Development of Roadmaps for Priority Pathogens with Epidemic

    Since 2016, CIDRAP has been engaged in the development of research and development (R&D) roadmaps for priority pathogens, including those identified by the World Health Organization’s …

  8. WHO R&D Blueprint for Epidemics

    Nov 21, 2022 · As part of WHO’s response to the outbreak, the R&D Blueprint has been activated to accelerate diagnostics, vaccines and therapeutics for this novel coronavirus.

  9. Preparing for the next pandemic: Strengthening Africa’s vaccine ...

    Jan 24, 2025 · During the 2013 Ebola outbreak in West Africa, IDRC and international partners supported research to test a new vaccine in Guinea. This vaccine is now the cornerstone of …

  10. Developing a vaccine for Ebola – the case for coordination and …

    Jan 27, 2021 · There were two major outcomes. WHO developed an R&D blueprint for action to prevent epidemics. It sets out a list of priority pathogens for which we urgently need to develop …